Boston Scientific v. Nevro Corp.

Court of Appeals for the Federal Circuit·Decided March 10, 2022·No. 21-1775·Unpublished

Opinion

Case: 21-1775 Document: 37 Page: 1 Filed: 03/10/2022

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit

BOSTON SCIENTIFIC NEUROMODULATION CORP., Appellant

v.

NEVRO CORP.,

Appellee

2021-1775

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2019- 01284.

JUDGMENT

Z.W. JULIUS CHEN, Akin Gump Strauss Hauer & Feld LLP, Washington, DC, argued for appellant. Also represented by PRATIK A. SHAH; MICHAEL P. KAHN, New York, NY; DAVID A. CAINE, Arnold & Porter Kaye Scholer LLP, Palo Alto, CA; MATTHEW WOLF, Washington, DC.

RYAN C. MORRIS, Sidley Austin LLP, Washington, DC, argued for appellee. Also represented by THOMAS ANTHONY BROUGHAN, III; CHING-LEE FUKUDA, SHARON LEE, New

Case: 21-1775 Document: 37 Page: 2 Filed: 03/10/2022

York, NY; JON WRIGHT, Sterne Kessler Goldstein & Fox, PLLC, Washington, DC.

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (MOORE, Chief Judge, CHEN and HUGHES, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

March 10, 2022 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Free access — add to your briefcase to read the full text and ask questions with AI

Boston Scientific v. Nevro Corp., (Fed. Cir. 2022).

Boston Scientific v. Nevro Corp. (Boston Scientific v. Nevro Corp.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.